Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. France In Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. High public healthcare spending & strong per-capita health investment
3.2.1.2. Increased national lab capacity, testing awareness and volumes
3.2.1.3. Government support for innovative diagnostics
3.2.1.4. Improved validation and reimbursement pathways for new IVDs.
3.2.2. Market Restraints Analysis
3.2.2.1. Pricing pressure and tight cost containment measures
3.2.2.2. Regulatory complexity and IVDR-related burden
3.2.2.3. Limited volume growth for conventional IVD tests
3.2.3. Market Opportunity Analysis
3.2.4. Supply Chain Analysis
3.2.5. Distribution Channel
3.2.5.1. Direct Sales
3.2.5.2. Distributors Network
3.2.5.3. E-commerce and Online Platforms
3.2.5.4. Major Distributors
3.3. France In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Reimbursement Overview of IVDs and LDTs
3.5. Pricing Analysis
Chapter 4. France In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. France In Vitro Diagnostics Market: Product Movement Analysis, 2025 & 2033 (USD Billion)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
Chapter 5. France In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. France In Vitro Diagnostics Market: Technology Movement Analysis, 2025 & 2033 (USD Billion)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Units)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
Chapter 6. France In Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. France In Vitro Diagnostics Market: Application Movement Analysis, 2025 & 2033 (USD Billion)
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
Chapter 7. France In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. France In Vitro Diagnostics Market: Test Location Movement Analysis, 2025 & 2033 (USD Billion)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion)
Chapter 8. France In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. France In Vitro Diagnostics Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.3.2. Private
8.3.2.1. Private Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.3.3. Public
8.3.3.1. Public Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4.2. Private
8.4.2.1. Private Labs Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4.3. Public
8.4.3.1. Public Labs Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.5. Others
8.5.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Global and local Company Market Share Analysis, 2025
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.6. Company Profiles
9.6.1. Euroblo Scientific
9.6.1.1. Participant’s Overview
9.6.1.2. Financial Performance
9.6.1.3. Product Benchmarking
9.6.1.4. Recent Developments
9.6.2. Servibio
9.6.2.1. Participant’s Overview
9.6.2.2. Financial Performance
9.6.2.3. Product Benchmarking
9.6.2.4. Recent Developments
9.6.3. CliniSciences
9.6.3.1. Participant’s Overview
9.6.3.2. Financial Performance
9.6.3.3. Product Benchmarking
9.6.3.4. Recent Developments
9.6.4. Avantor, Inc.
9.6.4.1. Participant’s Overview
9.6.4.2. Financial Performance
9.6.4.3. Product Benchmarking
9.6.4.4. Recent Developments
9.6.5. QIAGEN
9.6.5.1. Participant’s Overview
9.6.5.2. Financial Performance
9.6.5.3. Product Benchmarking
9.6.5.4. Recent Developments
9.6.6. BD
9.6.6.1. Participant’s Overview
9.6.6.2. Financial Performance
9.6.6.3. Product Benchmarking
9.6.6.4. Recent Developments
9.6.7. bioMerieux SA
9.6.7.1. Participant’s Overview
9.6.7.2. Financial Performance
9.6.7.3. Product Benchmarking
9.6.7.4. Recent Developments
9.6.8. F. Hoffmann-La Roche Ltd.
9.6.8.1. Participant’s Overview
9.6.8.2. Financial Performance
9.6.8.3. Product Benchmarking
9.6.8.4. Recent Developments
9.6.9. QuidelOrtho Corporation
9.6.9.1. Participant’s Overview
9.6.9.2. Financial Performance
9.6.9.3. Product Benchmarking
9.6.9.4. Recent Developments
9.6.10. Abbott
9.6.10.1. Participant’s Overview
9.6.10.2. Financial Performance
9.6.10.3. Product Benchmarking
9.6.10.4. Recent Developments
9.6.11. Agilent Technologies, Inc.
9.6.11.1. Participant’s Overview
9.6.11.2. Financial Performance
9.6.11.3. Product Benchmarking
9.6.11.4. Recent Developments
9.6.12. Siemens Healthineers AG
9.6.12.1. Participant’s Overview
9.6.12.2. Financial Performance
9.6.12.3. Product Benchmarking
9.6.12.4. Recent Developments
9.6.13. Bio-Rad Laboratories, Inc.
9.6.13.1. Participant’s Overview
9.6.13.2. Financial Performance
9.6.13.3. Product Benchmarking
9.6.13.4. Recent Developments
9.6.14. Danaher
9.6.14.1. Participant’s Overview
9.6.14.2. Financial Performance
9.6.14.3. Product Benchmarking
9.6.14.4. Recent Developments
9.6.15. Sysmex Corporation
9.6.15.1. Participant’s Overview
9.6.15.2. Financial Performance
9.6.15.3. Product Benchmarking
9.6.15.4. Recent Developments
9.6.16. Charles River Laboratories
9.6.16.1. Participant’s Overview
9.6.16.2. Financial Performance
9.6.16.3. Product Benchmarking
9.6.16.4. Recent Developments
9.6.17. Quest Diagnostics Incorporated
9.6.17.1. Participant’s Overview
9.6.17.2. Financial Performance
9.6.17.3. Product Benchmarking
9.6.17.4. Recent Developments
9.6.18. Novacyt Group
9.6.18.1. Participant’s Overview
9.6.18.2. Financial Performance
9.6.18.3. Product Benchmarking
9.6.18.4. Recent Developments
9.6.19. Acobiom
9.6.19.1. Participant’s Overview
9.6.19.2. Financial Performance
9.6.19.3. Product Benchmarking
9.6.19.4. Recent Developments
9.6.20. Poly-Dtech
9.6.20.1. Participant’s Overview
9.6.20.2. Financial Performance
9.6.20.3. Product Benchmarking
9.6.20.4. Recent Developments
9.6.21. Biosynex.
9.6.21.1. Participant’s Overview
9.6.21.2. Financial Performance
9.6.21.3. Product Benchmarking
9.6.21.4. Recent Developments
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Regulatory Framework
Table 4. France In Vitro Diagnostics Market, By Region, 2021-2033 (USD Billion), (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 5. France In Vitro Diagnostics Market, By Product, 2021-2033 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 6. France In Vitro Diagnostics Market, By Technology, 2021-2033 (USD Billion), (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 7. France In Vitro Diagnostics Market, By Application, 2021-2033 (USD billion)
Table 8. France In Vitro Diagnostics Market, By End Use, 2021-2033 (USD Billion), (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 9. France In Vitro Diagnostics Market, By Test Location, 2021-2033 (USD Billion)
List of Figures
Figure 1 France In Vitro Diagnostics Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling For Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 In Vitro Diagnostic Market Snapshot
Figure 10 Parent Market Outlook, 2025
Figure 11 In Vitro Diagnostic Market Driver Impact
Figure 12 Global Elderly Population
Figure 13 New Cancer Cases By Year
Figure 14 In Vitro Diagnostic Market Restraint Impact
Figure 15 Market Entry Strategy
Figure 16 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Figure 17 Porter’s Five Forces Analysis
Figure 18 France IVD Market: Product Outlook And Key Takeaways
Figure 19 France IVD Market: Products Movement Analysis
Figure 20 Instruments Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 21 Reagents Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 22 Services Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 23 France IVD Market: Technology Outlook And Key Takeaways
Figure 24 IVD Market: Technology Movement Analysis
Figure 25 Immunoassay Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 26 Instruments Market For Immunoassay Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 27 Reagents Market For Immunoassay Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 28 Services Market For Immunoassay Estimates And Forecast, 2021-2033 (USD Billion)
Figure 29 Hematology Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 30 Instruments Market For Hematology Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 31 Reagents Market For Hematology Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 32 Services Market For Hematology Estimates And Forecast, 2021-2033 (USD Billion)
Figure 33 Clinical Chemistry Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 34 Instruments Market For Clinical Chemistry Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 35 Reagents Market For Clinical Chemistry Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 36 Services Market For Clinical Chemistry Estimates And Forecast, 2021-2033 (USD Billion)
Figure 37 Molecular Diagnostics Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 38 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 39 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 40 Services Market For Molecular Diagnostics Estimates And Forecast, 2021-2033 (USD Billion)
Figure 41 Coagulation Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 42 Instruments Market For Coagulation Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 43 Reagents Market For Coagulation Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 44 Services Market For Coagulation Estimates And Forecast, 2021-2033 (USD Billion)
Figure 45 Microbiology Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 46 Instruments Market For Microbiology Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 47 Reagents Market For Microbiology Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 48 Services Market For Microbiology Estimates And Forecast, 2021-2033 (USD Billion)
Figure 49 Others Market Estimates And Forecast, 2021-2033 (USD Billion)Billion, Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million
Figure 50 Instruments Others Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Figure 51 Reagents Others Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Figure 52 Services Market For Other Technology Estimates And Forecast, 2021-2033 (USD Billion)
Figure 53 France IVD Market: Application Outlook And Key Takeaways
Figure 54 France IVD Market: Application Movement Analysis
Figure 55 Infectious Diseases Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 56 Diabetes Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 57 Oncology Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 58 Cardiology Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 59 Nephrology Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 60 Autoimmune Diseases Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 61 Drug Testing Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 62 Other Market Estimates And Forecasts, 2021-2033 (USD Billion)
Figure 63 France IVD Market: End-Use Outlook And Key Takeaways
Figure 64 IVD Treatment Market: End-Use Movement Analysis
Figure 65 Hospitals Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 66 Laboratory Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 67 Other Market Estimates And Forecast, 2021-2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Figure 68 France IVD Market: Test Location Outlook And Key Takeaways
Figure 69 IVD Treatment Market: Test Location Movement Analysis
Figure 70 Point-Of-Care Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 71 Homecare Market Estimates And Forecast, 2021-2033 (USD Billion)
Figure 72 Other Market Estimates And Forecasts, 2021-2033 (USD Billion)
